Skip to main content

Oncology

Oncology

Targeting RNA polymerase I for breast cancer therapy

Dual MIF - D-DT Targeting to Enhance Immunotherapy Responses

Rosevix (Rosziqumab) A ROS1 Biologic for Invasive Cancers

Subscribe to Oncology